Status: current, Defined. Date: 31-Jan 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2970291000168110 | Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2970301000168111 | Irinotecan Hydrochloride Trihydrate (Ebewe) 500 mg/25 mL injection, 25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | Is a | Irinotecan Hydrochloride Trihydrate (Ebewe) | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | Is a | irinotecan hydrochloride trihydrate 500 mg/25 mL injection, vial | true | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | has unit of use | vial | true | Inferred relationship | Some | 858552868 | |
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | has intended active ingredient | irinotecan | true | Inferred relationship | Some | 858552867 | |
| Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | has Australian BoSS | irinotecan hydrochloride trihydrate | true | Inferred relationship | Some | 858552867 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irinotecan Hydrochloride Trihydrate (Ebewe) 500 mg/25 mL injection, 25 mL vial | has TPUU | True | Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Irinotecan Hydrochloride Trihydrate (Ebewe) 500 mg/25 mL injection, 25 mL vial | has TPUU | True | Irinotecan Hydrochloride Trihydrate (Ebewe) (irinotecan hydrochloride trihydrate 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR